酰胺质子转移成像鉴别低级别与高级别胶质瘤:对表观扩散系数和相对脑血容量的附加价值
研究纳入46例连续成人弥漫性胶质瘤患者,术前行酰胺质子转移成像、扩散张量成像和灌注MRI,评估酰胺质子转移信号对表观扩散系数和相对脑血容量鉴别高低级别胶质瘤的附加价值。结果显示酰胺质子转移信号随胶质瘤级别升高而升高;酰胺质子转移联合表观扩散系数较单用表观扩散系数显著改善鉴别能力(AUC 0.910 vs 0.888,P=0.007),而联合相对脑血容量较单用相对脑血容量未显著改善(AUC 0.923 vs 0.927,P=0.222)。
要点
- 酰胺质子转移信号随胶质瘤WHO级别升高而升高。
- 酰胺质子转移联合表观扩散系数较单用表观扩散系数显著改善高低级别胶质瘤鉴别(AUC 0.910 vs 0.888,P=0.007)。
- 酰胺质子转移联合相对脑血容量较单用相对脑血容量未显著改善鉴别(AUC 0.923 vs 0.927,P=0.222)。
核心结论
- 酰胺质子转移成像可能是一种有用的影像生物标志物,对表观扩散系数鉴别低级别与高级别胶质瘤具有附加价值。
研究设计与样本
- 纳入46例连续成人弥漫性胶质瘤患者,术前行酰胺质子转移成像、扩散张量成像和灌注MRI,按世界卫生组织级别比较酰胺质子转移信号,采用受试者工作特征分析和综合判别改善指数评估诊断能力及附加价值。
关键影像表现/征象
- 酰胺质子转移信号随胶质瘤级别升高而升高。
诊断标准与关键数值
- 酰胺质子转移、表观扩散系数和相对脑血容量的鉴别能力无显著差异。
- 酰胺质子转移联合表观扩散系数较单用表观扩散系数显著改善鉴别(AUC 0.910 vs 0.888,P=0.007)。
- 酰胺质子转移联合相对脑血容量较单用相对脑血容量未显著改善鉴别(AUC 0.923 vs 0.927,P=0.222)。
临床应用与阅片要点
- 酰胺质子转移成像可能作为表观扩散系数的辅助手段用于低级别与高级别胶质瘤的鉴别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the added value of amide proton transfer (APT) imaging to the apparent diffusion coefficient (ADC) from diffusion tensor imaging (DTI) and the relative cerebral blood volume (rCBV) from perfusion magnetic resonance imaging (MRI) for discriminating between high- and low-grade gliomas.
METHODS: Forty-six consecutive adult patients with diffuse gliomas who underwent preoperative APT imaging, DTI and perfusion MRI were enrolled. APT signals were compared according to the World Health Organization grade. The diagnostic ability and added value of the APT signal to the ADC and rCBV for discriminating between low- and high-grade gliomas were evaluated using receiver operating characteristic (ROC) analyses and integrated discrimination improvement.
RESULTS: The APT signal increased as the glioma grade increased. The discrimination abilities of the APT, ADC and rCBV values were not significantly different. Using both the APT signal and ADC significantly improved discrimination vs. the ADC alone (area under the ROC curve [AUC], 0.888 vs. 0.910; P = 0.007), whereas using both the APT signal and rCBV did not improve discrimination vs. the rCBV alone (AUC, 0.927 vs. 0.923; P = 0.222).
CONCLUSIONS: APT imaging may be a useful imaging biomarker that adds value to the ADC for discriminating between low- and high-grade gliomas.
KEY POINTS: • Higher APT values were correlated with higher glioma grades. • Adding the APT signal to the ADC improved glioma grading. • Adding the APT signal to rCBV did not improve glioma grading. • APT is a useful adjunct to the ADC for glioma grading.
引用
- Choi YS, Ahn SS, Lee SK, et al. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume. Eur Radiol. 2017. PMID: 28116517. doi:10.1007/s00330-017-4732-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。